Natural killer cell subpopulations in putative resistant individuals and patients with active Mycobacterium tuberculosis infection

Scandinavian Journal of Immunology

Volumn 68, Issue 1, 2008, Pages 92-102

  Barcelos, W ^a   Sathler Avelar, R ^b   Martins Filho, O A ^b   Carvalho, B N ^b   Guimaraes T M P D ^a   Miranda, S S ^a   Andrade, H M ^a   Oliveira, M H P ^c   Toledo, V P C P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c Centro de Saúde Oswaldo Cruz   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN;

ADULT; ARTICLE; CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; INNATE IMMUNITY; MACROPHAGE; MALE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 44849083121     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2008.02116.x     Document Type: Article

References (50)

1. Glassroth J. Tuberculosis 2004: challenges and opportunities. Trans Am Clin Climat Assoc 2005 116 : 293 310.
2. Kunst H. Diagnosis of latent tuberculosis infection: the potential role of new technologies. Resp Med 2006 100 : 2098 106.
3. Jacobsen M, Mattow J, Repsilber D, Kaufmann SH. Novel strategies to identify biomarkers in tuberculosis. Biol Chem (in press).
4. Bancroft G. The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 1993 5 : 503 10.
5. Biron CA, Nguyen KB, Pien GC et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999 17 : 189 220.
6. Brill KJ, Li Q, Larkin R et al. Human natural killer cells mediate killing of intracellular Mycobacterium tuberculosis H37Rv via granule-independent mechanisms. Infect Immun 2001 69 : 1755 65.
7. Nirmala R, Narayanan PR, Mathew R et al. Reduced NK activity in pulmonary tuberculosis patients with/without HIV infection: identifying the defective stage and studying the effect of interleukins on NK activity. Tuberculosis 2001 81 : 343 52.
8. Corominas M, Cardona V, Gonzales L et al. B-lymphocytes and co-stimulatory molecules in Mycobacterium tuberculosis infection. Int J Tuberc Lung Dis 2004 8 : 98 105.
9. + natural killer T cells in fast treatment responders. Clin Exp Immunol 2006 145 : 252 60.
10. Zahran WA, Ghonaim MM, Koura BA, El-Banna H, Ali SM, El-Sheikh N. Human natural killer T cells (NKT), NK and T cells in pulmonary tuberculosis: potential indicators for disease activity and prognosis. Egypt J Immunol 2006 13 : 67 78.
11. Barcelos W, Martins-Filho O, Guimarães TMPD et al. Peripheral blood mononuclear cells immunophenotyping in pulmonary tuberculosis patients before and after treatment. Microbiol Immunol 2006 50 : 597 605.
12. Godfrey DI, Kronenberg M. Going both ways: immune regulation via CD1d-dependent NKT cells. J Clin Invest 2004 114 : 1379 88.
13. Van der Vliet HJ, Molling JW, von Blomberg BM et al. The immunoregulatory role of CD1d-restricted natural killer T cells in disease. Clin Immunol 2004 112 : 8 23.
14. Hammond KJL, Kronenberg M. Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr Opin Immunol 2003 15 : 683 9.
15. Matsuda JL, Gapin I, Baron JL et al. Mouse Vα14i natural killer T cells are resistant to cytokine polarization in vitro. Proc Natl Acad Sci U S A 2003 100 : 8395 400.
16. + thymocytes. Int Immunol 1997 9 : 73 9.
17. Godfrey DI, Hammond KJ, Poultron LD et al. NKT cells: facts, functions and fallacies. Immunol Today 2000 21 : 573 83.
18. + cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression. Cell Immunol 1991 36 : 486 95.
19. high regulatory T lymphocytes. Scand J Immunol 2005 62 : 297 308.
20. bright subset. Blood 2001 97 : 3146 51.
21. dim natural killer cell subsets respond differentially to direct stimulation with Mycobacterium bovis bacillus Calmette-Guérin. Scand J Immunol 2005 62 : 498 506.
22. Carson WE, Giri JG, Lindemann MJ et al. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 1994 180 : 1395 403.
23. Wang KS, Frank DA, Ritz J. Interleukin-2 enhances the response of natural killer cells to interleukin-12 through up-regulation of the interleukin-12 receptor and STAT-4. Blood 2000 95 : 3183 90.
24. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptative and innate immunity. Blood 2003 101 : 3052 7.
25. Ferlazzo G, Thomas D, Lin SL et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 2004 172 : 1455 62.
26. bright NK cells are enriched at inflammatory sites and can engage with monocytes in a reciprocal program of activation. J Immunol 2004 173 : 6418 26.
27. Nagler A, Lanier LL, Cwirla S et al. Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989 143 : 3183 91.
28. bright cells in tuberculosis pleurisy. J Immunol 2005 175 : 6852 60.
29. - cells with low litic activity are possible precursors of mature natural killer cells. Cell Immunol 1997 180 : 132 42.
30. Ziegler-Heitbrock HW. Heterogeneity of human blood monocytes: the CD14+CD16+ subpopulation. Immunol Today 1996 17 : 424 8.
31. Schierloh P, Alemán M, Yokobori N et al. NK cell activity in tuberculosis is associated with impaired CD11a and ICAM-1 expression: a regulatory role of monocytes in NK activation. Immunology. 2005 116 : 541 52.
32. Hanai H, Iida T, Takeuchi K et al. Adsorptive Depletion of Elevated Proinflammatory CD14(+)CD16(+)DR(++) Monocytes in Patients With Inflammatory Bowel Disease. Am J Gastroenterol (in press).
33. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001 22 : 633 40.
34. + natural killer cells. APMIS 2000 108 : 831 7.
35. Vankayalapati R, Wizel B, Weis SE et al. The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J Immunol 2002 168 : 3451 7.
36. Esin S, Batoni G, Pardini M et al. Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin. Immunology 2004 112 : 143 52.
37. Schimidt KN, Leung B, Kwong M et al. APC independent activation of NK cells by Toll-like receptor 3 agonist double-stranded RNA. J Immunol 2004 172 : 138 43.
38. Chalifour A, Jeannin P, Gauchat J et al. Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers α-defensin production. Blood 2004 104 : 1778 84.
39. bright subset of NK cells is resistant to oxidant-induced cell death. J Immunol 2007 179 : 781 5.
40. Morandi B, Bougras G, Muller WA et al. NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-secretion. Eur J Immunol 2006 36 : 2394 400.
41. Kronenberg M, Gapin L. The unconventional lifestyle of NKT cells. Nat Rev Immunol 2002 2 : 557 68.
42. Vincent MS, Gumperz JE, Brenner MB. Understanding the function of CD1-restricted T cells. Nat Immunol 2003 4 : 517 23.
43. Ortaldo JR, Winkler-Pickett RT, Yagita H, Young HA. Comparative studies of CD3- and CD3+CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and poreforming protein expression. Cell Immunol 1991 136 : 486 95.
44. Kojo S, Tsutsumi A, Goto D, Sumida T. Low expression levels of soluble CD1d gene in patients with rheumatoid arthritis. J Rheumatol 2003 30 : 2524 8.
45. Emoto M, Miyamoto M, Emoto Y et al. Highly biased type 1 immune responses in mice deficient in LFA-1 in Listeria monocytogenes infection are caused by elevated IL-12 production by granulocytes. J Immunol 2003 171 : 3970 6.
46. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao HR. The regulatory role of Va14 NKT cells in innate and acquired immune response. Annu Rev Immunol 2003 21 : 483 513.
47. Van Kaer L. Regulation of immune responses by CD1d-restricted natural killer T cells. Immunol Res 2004 30 : 139 53.
48. Kulpraneet M, Sukwit S, Sumransurp K, Chuenchitra T, Santiwatanakul S, Srisurapanon S. Cytokine production in NK and NKT cells from Mycobacterium tuberculosis infected patients. Southeast Asian J Trop Med Public Health 2007 38 : 370 5.
49. Gerosa F, Baldani-Guerra B, Nisii C et al. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002 195 : 327 33.
50. Roy S, Barnes PF, Garg A, Wu S, Cosman D, Vankayalapati R. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J Immunol 2008 180 : 1729 36.